Editorial: Advances in molecular and pharmacological mechanisms of novel targeted therapies for melanoma
- Front Oncol. 2024 Apr 4:14:1403778. doi: 10.3389/fonc.2024.1403778.
Affiliations
- 1. Departamento de Análises Clínicas, Universidade Federal do Paraná, Curitiba, Paraná, Brazil.
- 2. Programa de Pós-Graduação em Ciências Farmacêuticas, Universidade Federal do Paraná, Curitiba, Paraná, Brazil.
- # Contributed equally.
PMID: 38638856
DOI: 10.3389/fonc.2024.1403778
Keywords
cancer biomarkers; drug repositioning; immunology; immunotherapy; melanoma; nanotechnology; skin cancer.
Products
-
Cat. No.Product NameDescriptionTargetResearch Area
-